Predictors for the risk and severity of post-thrombotic syndrome in vascular Behçet's disease

Aysun Aksoy1, Seda Colak2, Burcu Yagiz3, Belkıs Nihan Coskun3, Ahmet Omma2, Yasin Yildiz4, Alper Sari5, Nuh Atas6, Can Ilgin7, Ömer Karadag5, Abdülsamet Erden5, Ediz Dalkilic3, Naile Bolca8, Rabia Ergelen9, Mehmet Ruhi Onur10, Haner Direskeneli1, Fatma Alibaz-Oner1
1Division of Rheumatology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Turkey
2Division of Rheumatology, Numune Education and Research Hospital, Ankara, Turkey
3Division of Rheumatology, Department of Internal Medicine, School of Medicine, Uludag University, Bursa, Turkey
4Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Turkey
5Vasculitis Research Centre, Hacettepe University, Ankara, Turkey
6Division of Rheumatology, Department of Internal Medicine, School of Medicine, Gazi University, Ankara, Turkey
7Department of Public Health, School of Medicine, Marmara University, Istanbul, Turkey
8Department of Radiology, Uludag University School of Medicine, Bursa, Turkey
9Department of Radiology, School of Medicine, Marmara University, Istanbul, Turkey
10Department of Radiology, School of Medicine, Hacettepe University, Ankara, Turkey

Tài liệu tham khảo

Jennette, 2013, Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides, Clin Exp Nephrol, 17, 603, 10.1007/s10157-013-0869-6 Alibaz-Oner, 2015, Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses, Medicine (Baltimore), 94, e494, 10.1097/MD.0000000000000494 Tascilar, 2014, Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course, Rheumatology (Oxford), 53, 2018, 10.1093/rheumatology/keu233 Kahn, 2009, J Thromb Haemost, 7, 879, 10.1111/j.1538-7836.2009.03294.x Kahn, 2009, How I treat postthrombotic syndrome, Blood, 114, 4624, 10.1182/blood-2009-07-199174 Alibaz-Oner, 2016, Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease, J Vasc Surg Venous Lymphat Disord, 4, 301, 10.1016/j.jvsv.2016.01.003 Seyahi, 2015, Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behçet syndrome: an observational study, Medicine (Baltimore), 94, e1899, 10.1097/MD.0000000000001899 1990, Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's disease, Lancet, 335, 1078 Yilmaz, 2013, Patient-driven assessment of disease activity in Behçet’s syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet’s Syndrome Activity Score, Clin Exp Rheumatol, 31, 77 Hatemi, 2018, 2018 Update of the EULAR recommendations for the management of Behçet's syndrome, Ann Rheum Dis, 77, 808 Lurie, 2020, The 2020 update of the CEAP classification system and reporting standards, J Vasc Surg Venous Lymphat Disord, 8, 342, 10.1016/j.jvsv.2019.12.075 Vasquez, 2010, Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group, J Vasc Surg, 52, 1387, 10.1016/j.jvs.2010.06.161 Rutherford, 2000, Venous severity scoring: an adjunct to venous outcome assessment, J Vasc Surg, 31, 1307, 10.1067/mva.2000.107094 Hamper, 2007, Ultrasound evaluation of the lower extremity veins, Radiol Clin North Am, 45, 525, 10.1016/j.rcl.2007.04.013 Lubberts, 2016, What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis, Thromb Haemost, 116, 417, 10.1160/TH16-02-0152 Schulman, 2006, Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months, J Thromb Haemost, 4, 734, 10.1111/j.1538-7836.2006.01795.x Ende-Verhaar, 2019, Post-thrombotic syndrome: short and long-term incidence and risk factors, Thromb Res, 177, 102, 10.1016/j.thromres.2019.03.003 Ozguler, 2020, Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome, Rheumatology (Oxford), 59, 799, 10.1093/rheumatology/kez352 Kahn, 2008, Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis, Ann Intern Med, 149, 698, 10.7326/0003-4819-149-10-200811180-00004 Tick, 2010, Predictors of the post-thrombotic syndrome with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis, J Thromb Haemost, 8, 2685, 10.1111/j.1538-7836.2010.04065.x Tick, 2008, Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis, J Thromb Haemost, 6, 2075, 10.1111/j.1538-7836.2008.03180.x Johnson, 1995, Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up, J Vasc Surg, 21, 307, 10.1016/S0741-5214(95)70271-7 Prandoni, 1997, The clinical course of deep-vein thrombosis. prospective long-term follow up 528 symptomatic patients, Haematologica, 82, 423 Galanaud, 2013, Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency, J Thromb Haemost, 11, 474, 10.1111/jth.12106 Galanaud, 2018, Predictors of post-thrombotic ulcer after acute DVT: the RIETE registry, Thromb Haemost, 118, 320, 10.1160/TH17-08-0598 Dronkers, 2018, Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis, Thromb Haemost, 118, 1428, 10.1055/s-0038-1666859 Latella, 2010, Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis, J Thromb Haemost, 8, 2169, 10.1111/j.1538-7836.2010.04001.x Piovella, 2002, Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with DVT recurrence and new thrombosis, Haematologica, 87, 515 Labropoulos, 2017, Saphenous vein wall thickness in age and venous reflux-associated remodeling in adults, J Vasc Surg Venous Lymphat Disord, 5, 216, 10.1016/j.jvsv.2016.11.003 Chandrashekar, 2017, Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes, J Thromb Haemost, 15, 1989, 10.1111/jth.13793 Matsumoto, 1991, Vasculo-Behçet’s disease: a pathologic study of eight cases, Hum Pathol, 22, 45, 10.1016/0046-8177(91)90060-3 Seyahi, 2019, Increased vein wall thickness in Behçet disease, J Vasc Surg Venous Lymphat Disord, 7 Alibaz-Oner, 2019, Venous vessel wall thickness in lower extremity is increased in male patients with Behçet's disease, Clin Rheumatol, 38, 1447, 10.1007/s10067-019-04470-z Kisacik, 2012, Investigation of the veins in patients with Behçet's disease with no known vascular event by Doppler ultrasonography, Rheumatol Int, 32, 303, 10.1007/s00296-010-1603-2 Alibaz-Oner, 2014, Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behçet's disease without overt thrombosis, Clin Rheumatol, 33, 277, 10.1007/s10067-013-2382-4 Lee, 2015, Role of coexisting contralateral primary venous disease in development of post-thrombotic syndrome following catheter-based treatment of iliofemoral deep venous thrombosis, J Vasc Surg Venous Lymphat Disord, 3, 354, 10.1016/j.jvsv.2015.05.004 Chitsike, 2012, Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study, J Thromb Haemost, 10, 2039, 10.1111/j.1538-7836.2012.04872.x Van Dongen CJJ, 2005, Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome, J Thromb Haemost, 3, 939, 10.1111/j.1538-7836.2005.01333.x Rabinovich, 2015, Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome, J Thromb Haemost, 13, 398, 10.1111/jth.12814 Downing, 1998, Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis, J Vasc Surg, 28, 848, 10.1016/S0741-5214(98)70060-6 San Norberto, 2016, Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis, Vasa, 45, 133, 10.1024/0301-1526/a000507